Gupta Sunil K, Mohindra Sandeep, Sharma Bhawani S, Gupta Rahul, Chhabra Rajesh, Mukherjee Kanchan K, Tewari Manoj K, Pathak Ashis, Khandelwal Niranjan, Suresh Narain M, Khosla Virender K
Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Neurosurgery. 2006 Jun;58(6):1144-50; discussion 1144-50. doi: 10.1227/01.NEU.0000215950.85745.33.
Tuberculosis of the craniovertebral junction is an uncommon entity and its optimal management remains controversial. In this study, we present the evolution of management protocol of this disease in our institute in the past 3 decades.
A total of 51 patients with craniovertebral junction tuberculosis presenting as atlantoaxial dislocation from 1978 through 2004 were reviewed. The disease was rated from Stage I to Stage III, depending on the radiological findings. All patients received antitubercular treatment for 18 months. In the initial period of this study (1978-1986), all patients (n = 10) underwent surgery, usually a posterior fusion. In the second period (1987-1998), patients with less severe disease (Stages I and II, n = 14) were managed with external rigid immobilization, whereas patients with severe disease (Stage III, n = 11) underwent either a transoral decompression with or without posterior fusion or posterior fusion alone. More recently (1999-2004), all patients (n = 16) in all stages (Stages I-III) have been managed without surgery by a rigid external immobilization.
Except for two patients who died (one because of miliary tuberculosis, the other because of acute hydrocephalus), clinical recovery occurred in all. Follow-up imaging demonstrated radiological healing as well, with regrowth of the destroyed bone.
The mainstay of management of tuberculosis of the craniovertebral junction is prolonged antitubercular treatment with a rigid external immobilization. Surgery is not necessary, even in patients with advanced stages of disease. Complete clinical and radiological healing occurs in all patients with conservative treatment.
颅颈交界区结核是一种罕见疾病,其最佳治疗方案仍存在争议。在本研究中,我们展示了过去30年我院对该疾病治疗方案的演变。
回顾了1978年至2004年间共51例以寰枢椎脱位表现的颅颈交界区结核患者。根据影像学表现,将疾病分为I至III期。所有患者均接受了18个月的抗结核治疗。在本研究的初期(1978 - 1986年),所有患者(n = 10)均接受手术,通常为后路融合术。在第二期(1987 - 1998年),病情较轻的患者(I期和II期,n = 14)采用外固定支具治疗,而病情严重的患者(III期,n = 11)则接受经口减压术,可联合或不联合后路融合术,或仅行后路融合术。最近(1999 - 2004年),所有各期(I - III期)患者(n = 16)均通过外固定支具进行非手术治疗。
除2例患者死亡(1例死于粟粒性肺结核,另1例死于急性脑积水)外,所有患者均实现临床康复。随访影像学检查也显示病变骨有再生,达到了影像学愈合。
颅颈交界区结核的主要治疗方法是延长抗结核治疗并采用外固定支具。即使是疾病晚期患者也无需手术。所有患者经保守治疗均可实现完全的临床和影像学愈合。